BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 37438521)

  • 1. Co-transplantation of autologous T
    Park TY; Jeon J; Lee N; Kim J; Song B; Kim JH; Lee SK; Liu D; Cha Y; Kim M; Leblanc P; Herrington TM; Carter BS; Schweitzer JS; Kim KS
    Nature; 2023 Jul; 619(7970):606-615. PubMed ID: 37438521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docosahexaenoic acid promotes dopaminergic differentiation in induced pluripotent stem cells and inhibits teratoma formation in rats with Parkinson-like pathology.
    Chang YL; Chen SJ; Kao CL; Hung SC; Ding DC; Yu CC; Chen YJ; Ku HH; Lin CP; Lee KH; Chen YC; Wang JJ; Hsu CC; Chen LK; Li HY; Chiou SH
    Cell Transplant; 2012; 21(1):313-32. PubMed ID: 21669041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons.
    Sundberg M; Bogetofte H; Lawson T; Jansson J; Smith G; Astradsson A; Moore M; Osborn T; Cooper O; Spealman R; Hallett P; Isacson O
    Stem Cells; 2013 Aug; 31(8):1548-62. PubMed ID: 23666606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Human Primary with Human iPS Cell-Derived Dopaminergic Neuron Grafts in the Rat Model for Parkinson's Disease.
    Peng SP; Copray S
    Stem Cell Rev Rep; 2016 Feb; 12(1):105-20. PubMed ID: 26438376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human induced pluripotent stem cell-derived neurons improve motor asymmetry in a 6-hydroxydopamine-induced rat model of Parkinson's disease.
    Han F; Wang W; Chen B; Chen C; Li S; Lu X; Duan J; Zhang Y; Zhang YA; Guo W; Li G
    Cytotherapy; 2015 May; 17(5):665-79. PubMed ID: 25747741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model.
    Kikuchi T; Morizane A; Doi D; Magotani H; Onoe H; Hayashi T; Mizuma H; Takara S; Takahashi R; Inoue H; Morita S; Yamamoto M; Okita K; Nakagawa M; Parmar M; Takahashi J
    Nature; 2017 Aug; 548(7669):592-596. PubMed ID: 28858313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: ultrastructural evidence for synapse formation using tyrosine hydroxylase immunocytochemistry.
    Clarke DJ; Brundin P; Strecker RE; Nilsson OG; Björklund A; Lindvall O
    Exp Brain Res; 1988; 73(1):115-26. PubMed ID: 3145209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Rho Kinase Inhibitors on Grafts of Dopaminergic Cell Precursors in a Rat Model of Parkinson's Disease.
    Rodriguez-Pallares J; Rodriguez-Perez AI; Muñoz A; Parga JA; Toledo-Aral JJ; Labandeira-Garcia JL
    Stem Cells Transl Med; 2016 Jun; 5(6):804-15. PubMed ID: 27075764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryopreservation Maintains Functionality of Human iPSC Dopamine Neurons and Rescues Parkinsonian Phenotypes In Vivo.
    Wakeman DR; Hiller BM; Marmion DJ; McMahon CW; Corbett GT; Mangan KP; Ma J; Little LE; Xie Z; Perez-Rosello T; Guzman JN; Surmeier DJ; Kordower JH
    Stem Cell Reports; 2017 Jul; 9(1):149-161. PubMed ID: 28579395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased cell suspension concentration augments the survival rate of grafted tyrosine hydroxylase immunoreactive neurons.
    Terpstra BT; Collier TJ; Marchionini DM; Levine ND; Paumier KL; Sortwell CE
    J Neurosci Methods; 2007 Oct; 166(1):13-9. PubMed ID: 17706789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration of brain region-specific neuronal vulnerability in human iPSC-based model of familial Parkinson's disease.
    Brazdis RM; Alecu JE; Marsch D; Dahms A; Simmnacher K; Lörentz S; Brendler A; Schneider Y; Marxreiter F; Roybon L; Winner B; Xiang W; Prots I
    Hum Mol Genet; 2020 May; 29(7):1180-1191. PubMed ID: 32160287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult human olfactory epithelial-derived progenitors: a potential autologous source for cell-based treatment for Parkinson's disease.
    Wang M; Lu C; Roisen F
    Stem Cells Transl Med; 2012 Jun; 1(6):492-502. PubMed ID: 23197853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson's disease.
    Hallett PJ; Deleidi M; Astradsson A; Smith GA; Cooper O; Osborn TM; Sundberg M; Moore MA; Perez-Torres E; Brownell AL; Schumacher JM; Spealman RD; Isacson O
    Cell Stem Cell; 2015 Mar; 16(3):269-74. PubMed ID: 25732245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human iPSC-derived midbrain organoids functionally integrate into striatum circuits and restore motor function in a mouse model of Parkinson's disease.
    Zheng X; Han D; Liu W; Wang X; Pan N; Wang Y; Chen Z
    Theranostics; 2023; 13(8):2673-2692. PubMed ID: 37215566
    [No Abstract]   [Full Text] [Related]  

  • 15. Adjunctive use of the non-ionic surfactant Poloxamer 188 improves fetal dopaminergic cell survival and reinnervation in a neural transplantation strategy for Parkinson's disease.
    Quinn M; Mukhida K; Sadi D; Hong M; Mendez I
    Eur J Neurosci; 2008 Jan; 27(1):43-52. PubMed ID: 18093176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased survival of dopaminergic neurons in striatal grafts of fetal ventral mesencephalic cells exposed to neurotrophin-3 or glial cell line-derived neurotrophic factor.
    Espejo M; Cutillas B; Arenas TE; Ambrosio S
    Cell Transplant; 2000; 9(1):45-53. PubMed ID: 10784066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise Promotes Neurite Extensions from Grafted Dopaminergic Neurons in the Direction of the Dorsolateral Striatum in Parkinson's Disease Model Rats.
    Torikoshi S; Morizane A; Shimogawa T; Samata B; Miyamoto S; Takahashi J
    J Parkinsons Dis; 2020; 10(2):511-521. PubMed ID: 31929121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival and maturation of human induced pluripotent stem cell-derived dopaminergic progenitors in the parkinsonian rat brain is enhanced by transplantation in a neurotrophin-enriched hydrogel.
    Comini G; Kelly R; Jarrin S; Patton T; Narasimhan K; Pandit A; Drummond N; Kunath T; Dowd E
    J Neural Eng; 2024 Mar; 21(2):. PubMed ID: 38479026
    [No Abstract]   [Full Text] [Related]  

  • 19. Reversal of dopaminergic degeneration in a parkinsonian rat following micrografting of human bone marrow-derived neural progenitors.
    Glavaski-Joksimovic A; Virag T; Chang QA; West NC; Mangatu TA; McGrogan MP; Dugich-Djordjevic M; Bohn MC
    Cell Transplant; 2009; 18(7):801-14. PubMed ID: 19796495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional effect of FGF2- and FGF8-expanded ventral mesencephalic precursor cells in a rat model of Parkinson's disease.
    Jensen P; Pedersen EG; Zimmer J; Widmer HR; Meyer M
    Brain Res; 2008 Jul; 1218():13-20. PubMed ID: 18513704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.